Bioabsorbable stents in routine practice. New epoch in interventional cardiology
نویسندگان
چکیده
منابع مشابه
Contemporary Reviews in Interventional Cardiology Bioabsorbable Coronary Stents
Percutaneous coronary intervention (PCI) with bioabsorbable stents has created interest because the need for mechanical support for the healing artery is temporary, and beyond the first few months there are potential disadvantages of a permanent metallic prosthesis. Stents improve immediate outcomes, including profoundly reducing acute vessel occlusion after PCI by scaffolding intimal tissue fl...
متن کاملDrug Eluting Stents; A new era in Interventional Cardiology
INTRODUCTION Over the last decade or so, no other subspecialty of medicine has seen such technological innovations, as interventional cardiology. These advances have revolutionized the management of coronary artery disease. From statin drugs to oral platelets inhibitors like clopidogrel and ticlopidine, intravenous platelet glycoprotein IIb/IIIa receptor blockers like Abciximab (Reo-Pro), Eptif...
متن کاملEverolimus-eluting stents in interventional cardiology
Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis. First-generation drug-eluting stents successfully countered the restenosis rate, but were hampered by concerns about their long-term safety. Second generation drug-eluting stents have combined the low restenosis rate of the first generation with improved long-term safety. We review the evol...
متن کامل18th Interventional Cardiology Workshop New Frontiers in Interventional Cardiology
s of original contributions from NFIC 2017 353 Advances in Interventional Cardiology 2017; 13, 4 (50) 1-P Economic outcomes of the CAT-CAD randomised trial assessing Coronary Artery computed Tomography as the first-choice anatomic test for individuals with suspected significant Coronary Artery Disease Piotr N. Rudzinski, Mariusz Kruk, Cezary Kepka, Zofia Dzielinska, Jerzy Pregowski, Adam Witkow...
متن کاملNew Horizons in InterVentional Cardiology.
represented at IAGS, I would like to remind you that about three quarters of all medical device industry players have 100 employees, or less. It is also well recognized that over the years many of the true innovations have originated in small, less structured and less risk averse environments. I would like to thank Dr. Myler for recognizing that dynamic and for giving me the opportunity to part...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cor et Vasa
سال: 2017
ISSN: 0010-8650,1803-7712
DOI: 10.1016/j.crvasa.2016.11.007